Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

• Main Authors: Schuler, M, Berardi, R, Lim, W-T, de Jonge, M, Bauer, TM, Azaro, A, Gottfried, M, Han, J-Y, Lee, DH, Wollner, M, Hong, DS, Vogel, A, Delmonte, A, Akimov, M, Ghebremariam, S, Cui, X, Nwana, N, Giovannini, M, Kim, TM
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Language: English
• Published: ELSEVIER 2024
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; capmatinib; MET amplification; MET exon 14; MET mutation; NSCLC; GENE COPY NUMBER; MET AMPLIFICATION; ACQUIRED-RESISTANCE; MUTATIONS; EGFR; ONARTUZUMAB; COMBINATION; ACTIVATION; GEFITINIB; ERLOTINIB
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/248920
• Institution: National University of Singapore

10.1016/j.annonc.2020.03.293